ZEALAND PHARMA A/S (22Z.DE) Stock Analyst Ratings
FRA:22Z • DK0060257814
52.6 EUR
-1.32 (-2.45%)
Last: Feb 20, 2026, 07:00 PM
ChartMill assigns a Buy % Consensus number of 82% to 22Z.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 96.27. This target is 83.02% above the current price.
- 22Z.DE was analyzed by 24 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about 22Z.DE.
- In the previous month the buy percentage consensus was at a similar level.
- 22Z.DE was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
ZEALAND PHARMA A/S / 22Z.DE FAQ
What is the average price target for ZEALAND PHARMA A/S (22Z.DE) stock?
24 analysts have analysed 22Z.DE and the average price target is 96.27 EUR. This implies a price increase of 83.02% is expected in the next year compared to the current price of 52.6.
Can you provide the consensus rating for ZEALAND PHARMA A/S stock?
The consensus rating for ZEALAND PHARMA A/S (22Z.DE) is 81.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for ZEALAND PHARMA A/S stock?
The number of analysts covering ZEALAND PHARMA A/S (22Z.DE) is 24.